Key populations brief
Accessed November 2017
Global Plan to end TB 2016-2020
Rapport sur les populations clès
Accessed November 2017
Key populations brief
Accessed 2017
СЕЛЬСКОЕ НАСЕЛЕНИЕ
ОСНОВНЫЕ ЗАТРОНУТЫЕ ГРУППЫ НАСЕЛЕНИЯ. КРАТКОЕ РУКОВОДСТВО.
Key populations brief
Accessed 2017
Informe sobre poblaciones clave
Technical Brief
HIV patient monitoring and case surveillance
WHO/HIV/2017.11
3rd Edition – July 2017
www.msfaccess.org
Topics in Antiviral Medicine 25 Issue 2 May/June 2017
Technical Update
HIV Treatment
July 2017
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...ted. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
more